Out-of-pocket healthcare spending in the U.S. increased across all states and demographic groups in 2017, following a three-year upward trend that culminated in a record year-over-year growth rate, according to a report from JPMorgan Chase Institute.

Sharon Gibbs, director of the radiology department at VCU Health in Richmond, Virginia, aims to provide quality, timely and efficient care. To do so, she must define, analyze and track the metrics and quality needs of her large care providing team, which consists of more than 40 faculty radiologists, over 200 technologists, and numerous other stakeholders. Gibbs knew that a single analytics solution would enable her to gather data more quickly.

Change Healthcare is primarily known for its state-of-the-art technology and business solutions, but the company also provides consulting services, including overall assessments of an organization’s overall business health. Sometimes, healthcare providers know they need help keeping up with the rest of the industry, but need to be pointed in the right direction before they can get started; that’s where Change Healthcare enters the equation.

One way that has been suggested to limit concussions in football is to rethink kickoff returns, when a player catches the ball in the open field and tries to move as far as possible without being tackled by the opposing team. Could changing these plays really help limit concussions?

For the team at Roper Radiologists PA (RR) in Charleston, South Carolina, organization plays a pivotal role. And in 2017, the practice found itself at a bit of a crossroads. They wanted more advanced tools at their fingertips for assigning reads and filtering worklists, but they felt limited by their available tools.

The FDA approved a new flu medicine that could shorten the time people are sick—and it can be taken in one dose.

A pending lawsuit launched by Republicans is threatening to overturn the Affordable Care Act—and the effects could impact 15 million people, according to a recent report from the ranking member of the House Committee on Oversight and Government Reform Rep. Elijah E. Cummings (D-MD).

Amgen is slashing the list price of its PCSK9 inhibitor evolocumab (Repatha) by almost 60 percent, the company announced Oct. 24.